Login/Sign Up
Should a patient continue their prescribed regimen of glimepiride 1 mg (Azulix) and metformin 500 mg SR (Glycomet) twice daily if their blood glucose levels have improved from a fasting level of 128 mg/dL and postprandial level of 220 mg/dL to a fasting level of 115 mg/dL and postprandial level of 105 mg/dL over a 45-day period?
Should a patient continue their prescribed regimen of glimepiride 1 mg (Azulix) and metformin 500 mg SR (Glycomet) twice daily if their blood glucose levels have improved from a fasting level of 128 mg/dL and postprandial level of 220 mg/dL to a fasting level of 115 mg/dL and postprandial level of 105 mg/dL over a 45-day period?
Answered 13 days ago